Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful dermatologic disease, a Stanford Medicine-led clinical trial has shown. The ...

Five years after a Fourth of July fireworks accident blinded him, a young man has regained his eyesight thanks to a ...

The Innovation Center of NanoMedicine has summarized the results of its collaborative research with Professor Kanjiro ...

Dr. Omar Llaguna, specialist in surgical oncology, programs a HistoSonics medical device for targeting a medium that mimics a liver tumor in a human body to demonstrate how a histotripsy procedure ...

Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without ...

Tarlatamab improved PFS and OS over chemotherapy as second-line treatment in patients with SCLC in the phase 3 DeLLphi-304 trial.

A new stem cell treatment restores vision using patients’ own eye cells — with a 93% success rate and no rejection risk. A leap forward in eye regeneration.

Some doctors told him he'd live with the disease forever, but Khaled Alsheebani never stopped believing treatments would advance one day.

Please provide your email address to receive an email when new articles are posted on . Living-related conjunctival limbal allograft allows for tissue typing and reduces rejection. The specialist ...

The treatment, called a cultivated autologous limbal epithelial cell transplantation -- or CALEC -- can help restore surface corneal epithelial cells, which can be destroyed after chemical burns ...

He decided to take a chance on a clinical trial at Mass Eye and Ear for a procedure that's the first of its kind in the U.S. "The name of it is cultivated autologous limbal epithelial stem cell ...

It contains important limbal epithelial stem cells, which help repair minor injuries ... CALEC could soon become a standard treatment—giving hope to those once told their blindness was irreversible.